|
Volumn 3, Issue 4, 2002, Pages 557-560
|
Rubicon Genomics, Inc
|
Author keywords
Amplification; Diagnostics; DNA amplification; DNA archive; Drug development; Genotype; Haplotype; Pharmacogenomics; SNP; Tissue bank; Whole genome
|
Indexed keywords
DNA;
REAGENT;
ACCURACY;
ANALYTIC METHOD;
ARTICLE;
DIAGNOSTIC PROCEDURE;
DNA DETERMINATION;
DRUG EFFICACY;
DRUG INDUSTRY;
DRUG SAFETY;
DRUG TARGETING;
ECONOMIC ASPECT;
GENE AMPLIFICATION;
GENE TECHNOLOGY;
GENOTYPE;
HAPLOTYPE;
HUMAN;
INSTRUMENTATION;
MARKETING;
MEDICAL PRACTICE;
PHARMACOGENOMICS;
SCORING SYSTEM;
SINGLE NUCLEOTIDE POLYMORPHISM;
DRUG DESIGN;
GENETICS;
PHARMACOGENETICS;
DNA;
DRUG DESIGN;
DRUG INDUSTRY;
GENOTYPE;
HAPLOTYPES;
HUMAN;
PHARMACOGENETICS;
POLYMORPHISM, SINGLE NUCLEOTIDE;
HUMANS;
|
EID: 0036020666
PISSN: 14622416
EISSN: None
Source Type: Journal
DOI: 10.1517/14622416.3.4.557 Document Type: Article |
Times cited : (69)
|
References (0)
|